INTEGRATED CARE PARTNERSHIP - OCH — All Prescriptions & Medications — Page 6
Practice Code: H81133 | EPSOM, KT17 4BL
Showing results 251-300 of 799
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Powder extensively hydrolysed formula (0913101) | 222 | 565.2K | £16.5K | +208.2% ▲ |
| Combined ethinylestradiol 20mcg | 220 | 14.4K | £3.4K | +321.2% ▲ |
| Flecainide acetate | 219 | 27.9K | £1.2K | +180.5% ▲ |
| Powder thickener - gum based (0913161) | 218 | 188.5K | £10.6K | +190.3% ▲ |
| Isophane insulin | 216 | 1,277 | £5.5K | +104.6% ▲ |
| Dihydrocodeine tartrate | 214 | 15.4K | £1.0K | +9.5% ▲ |
| Valproic acid | 211 | 8,850 | £2.6K | +142.5% ▲ |
| Tirzepatide | 211 | 299 | £28.9K | +8.6% ▲ |
| Olopatadine | 210 | 1,570 | £1.5K | +378.7% ▲ |
| Orlistat | 206 | 24.4K | £6.0K | +149.9% ▲ |
| Ticagrelor | 205 | 15.9K | £15.5K | +141.1% ▲ |
| Nicorandil | 204 | 15.0K | £2.2K | +41.7% ▲ |
| Biphasic insulin aspart | 204 | 1,981 | £11.8K | +100.9% ▲ |
| Benzydamine hydrochloride | 204 | 37.8K | £722 | +163.7% ▲ |
| Tolterodine | 202 | 15.9K | £2.3K | +35.9% ▲ |
| Nebivolol | 200 | 13.2K | £3.0K | +88.7% ▲ |
| 196 | 13.8K | £655 | +261.1% ▲ | |
| 196 | 23.1K | £1.4K | -9.4% ▼ | |
| Sulfasalazine | 193 | 25.0K | £5.4K | +48.3% ▲ |
| Verapamil hydrochloride | 193 | 12.7K | £1.1K | +112.7% ▲ |
| Fluticasone furoate/vilanterol | 193 | 290 | £7.4K | +24.7% ▲ |
| Metronidazole | 193 | 3,545 | £399 | +193.7% ▲ |
| Timolol | 191 | 6,673 | £1.7K | +116.0% ▲ |
| 191 | 6,820 | £31.5K | +322.4% ▲ | |
| Latanoprost and timolol | 190 | 6,203 | £3.2K | +148.8% ▲ |
| 190 | 2,189 | £280 | +405.3% ▲ | |
| Co-beneldopa (Benserazide/levodopa) | 189 | 30.9K | £2.0K | +25.0% ▲ |
| Emollient bath and shower preparations | 186 | 122.2K | £1.6K | +196.1% ▲ |
| Adapalene and benzoyl peroxide | 186 | 9,060 | £3.9K | +248.2% ▲ |
| Carbimazole | 185 | 12.6K | £811 | +63.8% ▲ |
| Sodium bicarbonate | 183 | 29.1K | £1.5K | +98.0% ▲ |
| Goserelin acetate | 182 | 182 | £21.8K | +313.1% ▲ |
| Specialist food replacer bread (0913271) | 182 | 351.5K | £3.3K | +319.3% ▲ |
| Ivabradine | 181 | 12.7K | £3.2K | +90.4% ▲ |
| Pizotifen malate | 181 | 11.0K | £494 | +119.6% ▲ |
| Erythromycin | 177 | 9,356 | £3.6K | +411.0% ▲ |
| Alogliptin/metformin | 175 | 17.8K | £8.1K | +319.5% ▲ |
| Azathioprine | 174 | 13.9K | £329 | +60.5% ▲ |
| 174 | 2,100 | £6.9K | +466.2% ▲ | |
| Hydrocortisone | 171 | 17.5K | £3.7K | +102.5% ▲ |
| Neomycin sulfate | 171 | 2,790 | £354 | +188.5% ▲ |
| 171 | 11.0K | £578 | +242.7% ▲ | |
| Carvedilol | 169 | 14.1K | £460 | +48.9% ▲ |
| Desmopressin acetate | 168 | 9,274 | £8.4K | +222.1% ▲ |
| Metoclopramide hydrochloride | 166 | 15.2K | £893 | +100.4% ▲ |
| Urea | 164 | 81.5K | £3.1K | +145.4% ▲ |
| Fenofibrate | 163 | 8,406 | £954 | +68.5% ▲ |
| Theophylline | 163 | 12.0K | £6.1K | +95.0% ▲ |
| 160 | 15.6K | £1.6K | +223.7% ▲ | |
| Rivastigmine | 156 | 9,120 | £5.3K | +126.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.